News

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
The evolving needs of Indian pharma industry encompass advanced skills in areas like biologics, AI, and automation ...
Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech ...
At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.
Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...
Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...
The Pharma AI Council officially launched today, establishing a new force to drive innovation and the responsible application ...
We hoped industry layoffs would relent in ... Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along ...
Learn more about whether BioCryst Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc. is a better investment based on ...